Management of anaphylaxis in the emergency setting

Expert Review of Clinical Immunology

Volumn 6, Issue 1, 2010, Pages 89-100

  Worth, Allison ^a   Soar, Jasmeet ^b   Sheikh, Aziz ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Adrenaline; Allergy; Anaphylaxis; Antihistamines; Corticosteroids; Emergency management; Epinephrine; Long term management

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; ATROPINE; BRONCHODILATING AGENT; CHLORPHENIRAMINE; GLUCAGON; GLUCOCORTICOID; HYDROCORTISONE; STEROID; VASOPRESSIN;

ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DEATH; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; EMERGENCY CARE; HUMAN; LOW DRUG DOSE; NONHUMAN; PRURITUS; RECOMMENDED DRUG DOSE; RESPIRATORY ARREST; REVIEW; RISK FACTOR; URTICARIA;

ALGORITHMS; ANAPHYLAXIS; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; EMERGENCY TREATMENT; EPINEPHRINE; FEMALE; FLUID THERAPY; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; MALE; OXYGEN INHALATION THERAPY; PATIENT POSITIONING; PRACTICE GUIDELINES AS TOPIC; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 77649110682     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.73     Document Type: Review

References (83)

1. Brown SGA. Anaphylaxis: clinical concepts and research priorities. Emerg. Med. Australas. 18, 155-169 (2006).
2. Simons FER, Sheikh A. Evidence-based management of anaphylaxis. Allergy 62, 827-829 (2007).
3. Sampson HA, Munoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J. Allergy Clin. Immunol. 117, 391-397 (2006).
4. Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis: an updated practice parameter. J. Allergy Clin. Immunol. 115, S483-S523 (2005).
5. American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10.6: Anaphylaxis. Circulation 112(Suppl. 1), IV-143-IV-145 (2005).
6. Soar J, Pumphrey R, Cant A et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 77(2), 157-169 (2008).
7. Muraro A, Roberts G, Clark A et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 62, 857-871 (2007).
8. Alsrabi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 62, 838-841 (2007).
9. Andreae DA, Andreae MH. Should antihistamines be used to treat anaphylaxis? Br. Med J. 339, b2489 (2009).
10. Kemp SF, Lockey RF, Simons FER; on behalf of the World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization (WAO). Allergy 63, 1061-1070 (2008).
11. Gompels LL, Bethune C, Johnston SL, Gompels MM. Proposed use of adrenaline (epinephrine) in anaphylaxis and related conditions: a study of senior house officers starting accident and emergency posts. Postgrad. Med. J. 78, 416-418 (2002).
12. Clark S, Bock SA, Gaeta TJ, Brennar BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. J. Allergy Clin. Immunol. 113, 347-352 (2004). (Pubitemid 38210561)
13. Chinn D, Sheikh A. Epidemiology of anaphylaxis. In: Allergy Frontiers: Epigenetics, Allergens and Risk Factors. Pawankar R, Holgate ST, Rosenwasser LJ (Eds). Springer, Tokyo, Japan, 123-144 (2009).
14. Lieberman P, Camargo CA, Bohlke K et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann. Allergy Asthma Immunol. 97(5), 596-602 (2006).
15. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J. Allergy Clin. Immunol. 113, 536-542 (2004).
16. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60, 443-451 (2005).
17. Braganza SC, Acworth JP, Mckinnon DRL, Peake JE, Brown AFT. Paediatric emergency department anaphylaxis: different patterns from adults. Arch. Dis. Child. 91, 159-163 (2006).
18. Smit de V, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J. Emerg. Med. 28, 381-388 (2005).
19. Sørensen HT, Nielsen B, Nielson-Østergaard J. Anaphylactic shock occurring outside hospitals. Allergy 44, 288-290 (1989).
20. Pumphrey R, Gowland H. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J. Allergy Clin. Immunol. 119, 1018-1019 (2007).
21. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. An investigation into its epidemiology. Arch. Intern. Med. 161, 15-21 (2001).
22. Lieberman P, Decker W, Camargo CA, O'Connor R, Oppenheimer J, Simons FE. SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department. Ann. Allergy Asthma Immunol. 98, 519-523 (2007).
23. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J. Allergy Clin. Immunol. 119, 1016-1018 (2007).
24. Simons FER, Frew AJ, Ansotegui IJ et al. Risk assessment in anaphylaxis: current and future approaches. J. Allergy Clin. Immunol. 120, S2-S24 (2007).
25. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 111, 1601-1608 (2003).
26. Chapman JA, Bernstein L, Lee RE et al. Food allergy: a practice parameter. Ann. Allergy Asthma Immunol. 96, S1-S68 (2006).
27. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions acute anaphylaxis: analysis of four years English hospital data. Clin. Exp. Allergy. 31, 1571-1576 (2001).
28. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 62(1), 91-96 (2007).
29. Simons FER, Sampson HA. Anaphylaxis epidemic: fact or fiction? J. Allergy Clin. Immunol. 122, 1166-1168 (2008).
30. Decker WW, Campbell RL, Manivannan V et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J. Allergy Clin. Immunol. 122, 1161-1165 (2008).
31. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. J. Allergy Clin. Immunol. 117, 367-377 (2006).
32. Alves B, Sheikh A. Age specific aetiology of anaphylaxis. Arch. Dis. Child. 85, 348 (2001).
33. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann. Allergy Asthma Immunol. 97, 39-43 (2006).
34. Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. In: Anaphylaxis. Novartis Foundation Symposium 257, Wiley, Chichester, UK, 6-24 (2004).
35. Simons FER. Anaphylaxis in infants: can recognition and management be improved? J. Allergy Clin. Immunol. 120, 537-540 (2007).
36. Lieberman P. Biphasic anaphylactic reactions. Ann. Allergy Asthma Immunol. 95, 217-226 (2005).
37. Brown SG. Clinical features and severity grading of anaphylaxis. J. Allergy Clin. Immunol. 114(2), 371-376 (2004).
38. Walker S, Sheikh A. Managing anaphylaxis: effective emergency and long-term care are necessary. Clin. Exp. Allergy 33, 1015-1018 (2003).
39. Sheikh A, ten Broek VM, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis: Cochrane Systematic Review. Allergy 62, 830-837 (2007). (Pubitemid 47037864)
40. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol. Allergy Clin. North Am. 26(3), 451-463 (2006).
41. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin. Exp. Allergy 33, 1033-1040 (2003).
42. Simons FER. Emergency treatment of anaphylaxis. Br. Med J. 336, 1141-1142 (2008).
43. Bautista E, Simons FE, Simons KJ et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int. Arch. Allergy Immunol. 128(2), 151-164 (2002).
44. Mink SN, Simons FER, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin. Exp. Allergy 34, 1776-1783 (2004).
45. Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 64, 204-212 (2009).
46. Clark S, Long AA, Gaeta TJ, Camargo CA Jr. Multicenter study of emergency department visits for insect sting allergies. J. Allergy Clin. Immunol. 116, 643-649 (2005).
47. Pongracic JA, Kim JS. Update on epinephrine for the treatment of anaphylaxis. Curr. Opin. Pediatr. 19, 94-98 (2007).
48. Gaeta TJ, Clark S, Pelletier A, Camargo CA. National study of US emergency department visits for acute allergic reactions. Ann. Allergy Asthma Immunol. 98, 360-365 (2007). (Pubitemid 46582128)
49. Pumphrey RSH. Fatal posture in anaphylactic shock. J. Allergy Clin. Immunol. 112, 451-452 (2003).
50. O'Driscoll BR, Howard LS, Davison AG. British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax 63(Suppl. 6), vi1-vi68 (2008).
51. Sheikh A, Simons FER, Choo KJL. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst. Rev. 1, CD007596 (2009).
52. Di Chiara L, Stazi GV, Ricci Z et al. Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report. J. Med. Case Reports 2, 36 (2008).
53. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can. J. Anesthesia 55, 437-440 (2008).
54. Shummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth. Analg. 107, 620-624 (2008).
55. Nurmatov U, Sheikh A. Investigating the role of vasopressin in anaphylactic shock. Prim. Care Respir. J. 17, 257 (2008).
56. Hiruta A, Mitsuhata H, Hiruta M et al. Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits. Shock 24(3), 264-269 (2005).
57. Dewachter P, Raeth-Fries I, Jouan-Hureaux V et al. A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 106, 977-983 (2007).
58. Thomas M, Crawford I. Glucagon infusion in refractory anaphylactic shock in patients on b-blockers. Emerg. Med. J. 22, 272-273 (2005).
59. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg. Med. Australas. 16(2), 120-124 (2004).
60. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors and observation recommendations. Immunol. Allergy Clin. North Am. 27, 309-326 (2007).
61. Cresswell KM, Sheikh A. Information technology-based approaches to reducing repeat drug exposure in patients with known drug allergies. J. Allergy Clin. Immunol. 121(5), 1112-1117 (2008).
62. Colver A. Are the dangers of childhood food allergy exaggerated? Br. Med J. 333, 494-496 (2006).
63. Hourihane J. Are the dangers of childhood food allergy exaggerated? Br. Med J. 333, 496-498 (2006).
64. Simons FE, Lieberman PL, Read EJ Jr, Edwards ES. Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review. Ann. Allergy Asthma Immunol. 102(4), 282-287 (2009).
65. Campbell RL, Luke A, Weaver AL et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann. Allergy Asthma Immunol. 101, 631-636 (2008).
66. Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J. Allergy Clin. Immunol. 117, 464-465 (2006).
67. Oren E, Banerji A, Clark S, Camargo CA. Food induced anaphylaxis and repeated epinephrine treatments. Ann. Allergy Asthma Immunol. 99, 429-432 (2007).
68. Jarvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J. Allergy Clin. Immunol. 122, 133-138 (2008).
69. Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 357, 111-115 (2001).
70. Hayman GR, Bansal JA, Bansal AS. Knowledge about using auto-injectable adrenaline: review of patients' case notes and interviews with general practitioners. Br. Med. J. 327(7427), 1328 (2003).
71. Simons FER, Chan ES, Gu X, Simons KJ. Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J. Allergy Clin. Immunol. 108, 1040-1044 (2001).
72. Simons FER, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J. Allergy Clin. Immunol. 109, 171-175 (2002).
73. Choo K, Sheikh A. Action plans for the long-term management of anaphylaxis: systematic review of effectiveness. Clin. Exp. Allergy 37(7), 1090-1094 (2007). (Pubitemid 46955514)
74. Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J. Allergy Clin. Immunol. 122(2), 353-361 (2008).
75. Hourihane JO. Community management of severe allergies must be integrated and comprehensive and consists of more than just epinephrine. Allergy 56, 1023-1025 (2001).
76. Ewan PW, Clark AT. Efficacy of a management plan based on severity assessment in longitudinal and case- controlled studies of 747 children with nut allergy: proposal for good practice. Clin. Exp. Allergy 35, 751-756 (2005).
77. Vickers DW, Maynard L, Ewan PW. Management of children with potential anaphylactic reactions in the community: a training package and proposal for good practice. Clin. Exp. Allergy 27, 898-903 (1997).
78. Moneret-Vautrin DA, Kanny G, Morisset M et al. Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit. Allergy 56, 1071-1076 (2001).
79. Melville N, Beattie T. Paediatric allergic reactions in the emergency department: a review. Emerg. Med. J. 25, 655-658 (2008).
80. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 64(8), 1218-1220 (2009).
81. Akashi M, Narita M, Saito A et al. Oral desensitization therapy in children with egg allergy. J. Allergy Clin. Immunol. 119(Suppl. 1), S74 (2007).
82. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62, 1261-1269 (2007).
83. Vadas P, Gold M, Perelman B et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 358(1), 28-35 (2008).